UK markets open in 47 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,464.62 +257.49 (+1.41%) CRUDE OIL
79.14 +0.19 (+0.24%) GOLD FUTURES
2,314.40 +4.80 (+0.21%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,417.03 +1,604.42 (+3.50%)
Regen BioPharma, Inc. (RGBP)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:44PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.35M |
| Enterprise value | 2.96M |
| Trailing P/E | 31.20 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.08 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 12.52 |
| Enterprise value/EBITDA | -3.60 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.79 |
| 52-week change 3 | -63.23% |
| S&P500 52-week change 3 | 21.33% |
| 52-week high 3 | 2.5500 |
| 52-week low 3 | 0.4010 |
| 50-day moving average 3 | 0.7349 |
| 200-day moving average 3 | 1.2014 |
Share statistics
| Avg vol (3-month) 3 | 14.67k |
| Avg vol (10-day) 3 | 4.76k |
| Shares outstanding 5 | 4.11M |
| Implied shares outstanding 6 | 4.11M |
| Float 8 | 4.11M |
| % held by insiders 1 | 0.01% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:1500 |
| Last split date 3 | 06 Mar 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -171.12% |
Management effectiveness
| Return on assets (ttm) | -84.06% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 236.56k |
| Revenue per share (ttm) | 0.06 |
| Quarterly revenue growth (yoy) | 0.00% |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -839.79k |
| Diluted EPS (ttm) | -0.2400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 78.11k |
| Total cash per share (mrq) | 0.02 |
| Total debt (mrq) | 693.77k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.02 |
| Book value per share (mrq) | -1.26 |
Cash flow statement
| Operating cash flow (ttm) | -482.07k |
| Levered free cash flow (ttm) | -66.86k |
© 2024 Yahoo. All rights reserved.